Procyon Corp financial data

Symbol
PCYN on OTC
Industry
Pharmaceutical Preparations
Location
1300 S Highland Ave, Clearwater, FL
State of incorporation
CO
Fiscal year end
June 30
Latest financial report
10-K - Q2 2024 - Oct 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 329 % -20.7%
Quick Ratio 78.2 % -23.9%
Debt-to-equity 37.7 % +4.73%
Return On Equity -14.4 % -654%
Return On Assets -10.5 % -645%
Operating Margin -4.65 % -124%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.12M shares +0.41%
Common Stock, Shares, Outstanding 8.12M shares +0.41%
Entity Public Float 1.02M USD -10.3%
Common Stock, Value, Issued 4.46M USD +0.39%
Weighted Average Number of Shares Outstanding, Basic 8.12M shares +0.41%
Weighted Average Number of Shares Outstanding, Diluted 8.12M shares +0.41%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.98M USD +6.35%
Operating Income (Loss) -232K USD -138%
Nonoperating Income (Expense) 60.4K USD +88.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -171K USD -162%
Income Tax Expense (Benefit) 170K USD -519%
Net Income (Loss) Attributable to Parent -341K USD -579%
Earnings Per Share, Basic -0.04 USD/shares -300%
Earnings Per Share, Diluted -0.04 USD/shares -300%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 513K USD +3.84%
Inventory, Net 510K USD +18.2%
Assets, Current 2.37M USD +5.73%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 262K USD -6.76%
Operating Lease, Right-of-Use Asset 338K USD -35.9%
Assets 3.2M USD -10.1%
Accounts Payable, Current 161K USD -8.08%
Liabilities, Current 769K USD +22.9%
Deferred Income Tax Liabilities, Net 8.68K USD
Operating Lease, Liability, Noncurrent 139K USD -56.5%
Liabilities 917K USD -3.05%
Retained Earnings (Accumulated Deficit) -2.33M USD -17.1%
Stockholders' Equity Attributable to Parent 2.29M USD -12.6%
Liabilities and Equity 3.2M USD -10.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.59K USD
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -53.4K USD -663%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 8.12M shares +0.41%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -48.8K USD +72.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 209K USD
Deferred Tax Assets, Gross 327K USD -0.96%
Operating Lease, Liability 320K USD -35.2%
Depreciation 19.2K USD +75.5%
Payments to Acquire Property, Plant, and Equipment 53.4K USD +663%
Property, Plant and Equipment, Gross 559K USD -7.94%
Operating Lease, Liability, Current 181K USD +4.09%
Lessee, Operating Lease, Liability, to be Paid, Year Two 141K USD -25.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 188K USD +1.92%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 141K USD
Deferred Tax Assets, Operating Loss Carryforwards 209K USD +15.2%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -7.76K USD -295%
Preferred Stock, Shares Authorized 496M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 359K USD
Additional Paid in Capital 41.1K USD +15.5%
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Share-based Payment Arrangement, Expense 7.71K USD -28.1%
Deferred State and Local Income Tax Expense (Benefit) -1.61K USD -296%